Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male

With extensive loss of life and well-being seen since the beginning of the SARS-CoV-2 pandemic, the initiation of vaccinations has come with enormous hope towards the end of this pandemic. Detailed discussions regarding the safety and efficacy of these vaccines led to their approval. With such succe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Habiba, Sehring, Matthew, Soriano, Sheryll
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516572/
https://www.ncbi.nlm.nih.gov/pubmed/34659839
http://dx.doi.org/10.1155/2021/7682655
_version_ 1784583833469845504
author Hussain, Habiba
Sehring, Matthew
Soriano, Sheryll
author_facet Hussain, Habiba
Sehring, Matthew
Soriano, Sheryll
author_sort Hussain, Habiba
collection PubMed
description With extensive loss of life and well-being seen since the beginning of the SARS-CoV-2 pandemic, the initiation of vaccinations has come with enormous hope towards the end of this pandemic. Detailed discussions regarding the safety and efficacy of these vaccines led to their approval. With such success, there have also been reports of vaccine-associated adverse events—allergic reactions, anaphylaxis, immune thrombocytopenia, and thrombosis. We discuss and report the first case of a healthy young adult male developing extensive thrombosis, after receiving the Ad26.COV2.S (Johnson & Johnson/Janssen) vaccine.
format Online
Article
Text
id pubmed-8516572
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-85165722021-10-15 Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male Hussain, Habiba Sehring, Matthew Soriano, Sheryll Case Rep Crit Care Case Report With extensive loss of life and well-being seen since the beginning of the SARS-CoV-2 pandemic, the initiation of vaccinations has come with enormous hope towards the end of this pandemic. Detailed discussions regarding the safety and efficacy of these vaccines led to their approval. With such success, there have also been reports of vaccine-associated adverse events—allergic reactions, anaphylaxis, immune thrombocytopenia, and thrombosis. We discuss and report the first case of a healthy young adult male developing extensive thrombosis, after receiving the Ad26.COV2.S (Johnson & Johnson/Janssen) vaccine. Hindawi 2021-10-14 /pmc/articles/PMC8516572/ /pubmed/34659839 http://dx.doi.org/10.1155/2021/7682655 Text en Copyright © 2021 Habiba Hussain et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Hussain, Habiba
Sehring, Matthew
Soriano, Sheryll
Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male
title Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male
title_full Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male
title_fullStr Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male
title_full_unstemmed Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male
title_short Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male
title_sort deep venous thrombosis after ad26.cov2.s vaccination in adult male
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516572/
https://www.ncbi.nlm.nih.gov/pubmed/34659839
http://dx.doi.org/10.1155/2021/7682655
work_keys_str_mv AT hussainhabiba deepvenousthrombosisafterad26cov2svaccinationinadultmale
AT sehringmatthew deepvenousthrombosisafterad26cov2svaccinationinadultmale
AT sorianosheryll deepvenousthrombosisafterad26cov2svaccinationinadultmale

Ejemplares similares